Having shown that A4 was the most potent compound in suppressing high-risk neuroblastoma in vitro, we sought to investigate the effect of targeting XIAP by A4 in vivo using PDX models of neuroblastoma. The gene discussed is XIAP; the disease is neuroblastoma.